Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yuanlei Fu"'
Publikováno v:
MedComm, Vol 5, Iss 2, Pp n/a-n/a (2024)
Abstract Drug development is a long and costly process, with a high degree of uncertainty from the identification of a drug target to its market launch. Targeted drugs supported by human genetic evidence are expected to enter phase II/III clinical tr
Externí odkaz:
https://doaj.org/article/b36e27012b384aeaa5b420db3431b649
Autor:
Yuanlei Fu, Ying Kong, Xiangping Li, Dongfang Cheng, Yuqian Hou, Yan Li, Tongfang Li, Yani Xiao, Qiuyan Zhang, Rong Rong
Publikováno v:
Drug Delivery, Vol 30, Iss 1 (2023)
AbstractPt(IV) compounds are regarded as prodrugs of active Pt(II) drugs (i.e. cisplatin, carboplatin, and oxaliplatin) and burgeoned as the most ideal candidates to substitute Pt(II) anticancer drugs with severe side effects. Nanoparticle drug deliv
Externí odkaz:
https://doaj.org/article/fefc5324e8a54fadab9673d14ea8d332
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1272-1280 (2021)
Chemotherapy plays a major role in the treatment of cancer, but it still has great limitations in anti-tumor effect. Carboplatin (CAR) is the first-line drug in the treatment of non-small cell lung cancer, but the therapeutic effect is demonstrated w
Externí odkaz:
https://doaj.org/article/a0f72f0ca8514a93b99f4214ddb80b80
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not on
Externí odkaz:
https://doaj.org/article/a37648477f8c4f58b86cf3952c12688f
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1272-1280 (2021)
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery
article-version (VoR) Version of Record
Chemotherapy plays a major role in the treatment of cancer, but it still has great limitations in anti-tumor effect. Carboplatin (CAR) is the first-line drug in the treatment of non-small cell lung cancer, but the therapeutic effect is demonstrated w
Autor:
Haijun Yu, Zhiwen Zhang, Tingting Wang, Jianping Liu, Zhiai Xu, Yuanlei Fu, Yaping Li, Bing Feng, Qi Yin, Fangyuan Zhou, Dangge Wang
Publikováno v:
Advanced Functional Materials. 26:7431-7442
Integration of chemotherapy with photodynamic therapy (PDT) has been emerging as a novel strategy for treatment of triple negative breast cancer (TNBC). However, the clinical translation of this approach is hindered by the unwanted dark toxicity due
Autor:
Zhiwen Zhang, Yaping Li, Pengcheng Zhang, Zhaocai Zhou, Haijun Yu, Qi Yin, Shi Jiao, Dangge Wang, Tingting Wang, Jianping Liu, Yuanlei Fu, Fangyuan Zhou, Bing Feng
Publikováno v:
Nano letters. 16(9)
Photodynamic therapy (PDT) has emerged as a promising clinical modality for cancer therapy due to its ability to initiate an antitumor immune response. However, PDT-mediated cancer immunotherapy is severely impaired by tumor-cell immunosuppression of
Autor:
Dangge Wang, Tingting Wang, Jianping Liu, Haijun Yu, Shi Jiao, Bing Feng, Fangyuan Zhou, Yuanlei Fu, Qi Yin, Pengcheng Zhang, Zhiwen Zhang, Zhaocai Zhou, Yaping Li
Publikováno v:
Nano Letters; Sep2016, Vol. 16 Issue 9, p5503-5513, 11p